Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
April-2018 Volume 41 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2018 Volume 41 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Targeted disruption of adenosine kinase in myeloid monocyte cells increases osteoclastogenesis and bone resorption in mice

  • Authors:
    • Qiuying Ye
    • Ge Li
    • Shuhua Liu
    • Yalun Guan
    • Yunfeng Li
    • Jinling Li
    • Huanhuan Jia
    • Xuejiao Li
    • Qingnan Li
    • Ren Huang
    • Hui Wang
    • Yu Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Food and Drugs, Qingyuan Polytechnic, Qingyuan, Guangdong 511510, P.R. China, Guangdong Laboratory Animals Monitoring Institute, Guangdong Provincial Key Laboratory of Laboratory Animals, Guangzhou, Guangdong 510663, P.R. China
  • Pages: 2177-2184
    |
    Published online on: January 17, 2018
       https://doi.org/10.3892/ijmm.2018.3394
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Adenosine kinase (ADK) serves an important role in intracellular adenosine clearance via phosphorylating adenosine to AMP. The role of adenosine and its receptors in the maintenance of bone homeostasis is well studied, particularly in osteoclastogenesis and bone resorption; however, the function of ADK in bone metabolism is still unclear. In the present study, utilizing the cre/floxp recombination system, mice with conditional loss of ADK function in myeloid monocyte cells were used to assess the effect of ADK deficiency on bone metabolism. Mice were evaluated by means of gross observation and bone histomorphometric analysis. Ex vivo osteoclast differentiation and bone resorption were also examined using genetic deletion and pharmacologic inhibition of ADK in osteoclasts. Compared with control mice, the results of the present study demonstrate that adult mice lacking ADK in the myeloid monocyte cells had reduced body weight and nasoanal length. The results of bone histomorphometric analysis revealed that bone mass was significantly decreased and osteoclastic parameters were increased in the study mice. Furthermore, in vitro cell culture revealed that inhibition of ADK function promoted osteoclast differentiation and bone resorption. Osteoclast‑associated gene expression, including tartrate‑resistant acid phosphatase, nuclear factor of activated T‑cells, cytoplasmic 1, matrix metalloproteinase 9, Cathepsin K and calcitonin receptor, was also significantly increased. These results suggest that mice with ADK deficiency have reduced bone formation due to increased osteoclastogenesis and bone resorption. The present study provides further insight into the mechanism by which ADK serves a key role in bone metabolism.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Boison D: Adenosine kinase: Exploitation for therapeutic gain. Pharmacol Rev. 65:906–943. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Andres CM and Fox IH: Purification and properties of human placental adenosine kinase. J Biol Chem. 254:11388–11393. 1979.PubMed/NCBI

3 

Antonioli L, Blandizzi C, Pacher P and Haskó G: Immunity, inflammation and cancer: A leading role for adenosine. Nat Rev Cancer. 13:842–857. 2013. View Article : Google Scholar : PubMed/NCBI

4 

Boison D: The adenosine kinase hypothesis of epileptogenesis. Prog Neurobiol. 84:249–262. 2008. View Article : Google Scholar : PubMed/NCBI

5 

Lusardi TA, Lytle NK, Szybala C and Boison D: Caffeine prevents acute mortality after TBI in rats without increased morbidity. Exp Neurol. 234:161–168. 2012. View Article : Google Scholar : PubMed/NCBI

6 

Pignataro G, Simon RP and Boison D: Transgenic overexpression of adenosine kinase aggravates cell death in ischemia. J Cereb Blood Flow Metab. 27:1–5. 2007. View Article : Google Scholar

7 

Pawelczyk T, Sakowicz M, Szczepanska-Konkel M and Angielski S: Decreased expression of adenosine kinase in streptozotocin-induced diabetes mellitus rats. Arch Biochem Biophys. 375:1–6. 2000. View Article : Google Scholar : PubMed/NCBI

8 

Giglioni S, Leoncini R, Aceto E, Chessa A, Civitelli S, Bernini A, Tanzini G, Carraro F, Pucci A and Vannoni D: Adenosine kinase gene expression in human colorectal cancer. Nucleosides Nucleotides Nucleic Acids. 27:750–754. 2008. View Article : Google Scholar : PubMed/NCBI

9 

Raggatt LJ and Partridge NC: Cellular and molecular mechanisms of bone remodeling. J Biol Chem. 285:25103–25108. 2010. View Article : Google Scholar : PubMed/NCBI

10 

Mediero A and Cronstein BN: Adenosine and bone metabolism. Trends Endocrinol Metab. 24:290–300. 2013. View Article : Google Scholar : PubMed/NCBI

11 

He W, Mazumder A, Wilder T and Cronstein BN: Adenosine regulates bone metabolism via A1, A2A, and A2B receptors in bone marrow cells from normal humans and patients with multiple myeloma. FASEB J. 27:3446–3454. 2013. View Article : Google Scholar : PubMed/NCBI

12 

He W and Cronstein BN: Adenosine A1 receptor regulates osteoclast formation by altering TRAF6/TAK1 signaling. Purinergic Signal. 8:327–337. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Mediero A, Kara FM, Wilder T and Cronstein BN: Adenosine A2A receptor ligation inhibits osteoclast formation. Am J Pathol. 180:775–786. 2012. View Article : Google Scholar :

14 

Corciulo C, Wilder T and Cronstein BN: Adenosine A2B receptors play an important role in bone homeostasis. Purinergic Signal. 12:537–547. 2016. View Article : Google Scholar : PubMed/NCBI

15 

Rath-Wolfson L, Bar-Yehuda S, Madi L, Ochaion A, Cohen S, Zabutti A and Fishman P: IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis. Clin Exp Rheumatol. 24:400–406. 2006.PubMed/NCBI

16 

Staufner C, Lindner M, Dionisi-Vici C, Freisinger P, Dobbelaere D, Douillard C, Makhseed N, Straub BK, Kahrizi K, Ballhausen D, et al: Adenosine kinase deficiency: Expanding the clinical spectrum and evaluating therapeutic options. J Inherit Metab Dis. 39:273–283. 2016. View Article : Google Scholar

17 

Boison D, Scheurer L, Zumsteg V, Rülicke T, Litynski P, Fowler B, Brandner S and Mohler H: Neonatal hepatic steatosis by disruption of the adenosine kinase gene. Proc Natl Acad Sci USA. 99:6985–6990. 2002. View Article : Google Scholar : PubMed/NCBI

18 

Massaro EJ and Rogers JM: The Skeleton: Biochemical, Genetic, and Molecular Interactions in Development and Homeostasis. Humana Press; Totowa, NJ: 2004, View Article : Google Scholar

19 

Sandau US, Colino-Oliveira M, Jones A, Saleumvong B, Coffman SQ, Liu L, Miranda-Lourenço C, Palminha C, Batalha VL, Xu Y, et al: Adenosine kinase deficiency in the brain results in maladaptive synaptic plasticity. J Neurosci. 36:12117–12128. 2016. View Article : Google Scholar : PubMed/NCBI

20 

Clausen BE, Burkhardt C, Reith W, Renkawitz R and Förster I: Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8:265–277. 1999. View Article : Google Scholar

21 

Takahashi N, Udagawa N, Tanaka S and Suda T: Generating murine osteoclasts from bone marrow. Methods Mol Med. 80:129–144. 2003.PubMed/NCBI

22 

Tevlin R, McArdle A, Chan CK, Pluvinage J, Walmsley GG, Wearda T, Marecic O, Hu MS, Paik KJ, Senarath-Yapa K, et al: Osteoclast derivation from mouse bone marrow. J Vis Exp. 6:e520562014.

23 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar

24 

Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR and Parfitt AM: Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry nomenclature committee. J Bone Miner Res. 28:2–17. 2013. View Article : Google Scholar :

25 

Bjursell MK, Blom HJ, Cayuela JA, Engvall ML, Lesko N, Balasubramaniam S, Brandberg G, Halldin M, Falkenberg M, Jakobs C, et al: Adenosine kinase deficiency disrupts the methionine cycle and causes hypermethioninemia, encephalopathy, and abnormal liver function. Am J Hum Genet. 89:507–515. 2011. View Article : Google Scholar : PubMed/NCBI

26 

Boyle WJ, Simonet WS and Lacey DL: Osteoclast differentiation and activation. Nature. 423:337–342. 2003. View Article : Google Scholar : PubMed/NCBI

27 

Albers J, Keller J, Baranowsky A, Beil FT, Catala-Lehnen P, Schulze J, Amling M and Schinke T: Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin. J Cell Biol. 200:537–549. 2013. View Article : Google Scholar : PubMed/NCBI

28 

Bartell SM, Kim HN, Ambrogini E, Han L, Iyer S, Serra Ucer S, Rabinovitch P, Jilka RL, Weinstein RS, Zhao H, et al: FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation. Nat Commun. 5:37732014. View Article : Google Scholar

29 

Kim HN, Han L, Iyer S, de Cabo R, Zhao H, O'Brien CA, Manolagas SC and Almeida M: Sirtuin1 suppresses osteoclastogenesis by deacetylating FoxOs. Mol Endocrinol. 29:1498–1509. 2015. View Article : Google Scholar : PubMed/NCBI

30 

Sun W, Zhao C, Li Y, Wang L, Nie G, Peng J, Wang A, Zhang P, Tian W, Li Q, et al: Osteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activity. Cell Discov. 2:160152016. View Article : Google Scholar : PubMed/NCBI

31 

Young JD, Yao SY, Sun L, Cass CE and Baldwin SA: Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins. Xenobiotica. 38:995–1021. 2008. View Article : Google Scholar : PubMed/NCBI

32 

Kara FM, Chitu V, Sloane J, Axelrod M, Fredholm BB, Stanley ER and Cronstein BN: Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function. FASEB J. 24:2325–2333. 2010. View Article : Google Scholar : PubMed/NCBI

33 

Kara FM, Doty SB, Boskey A, Goldring S, Zaidi M, Fredholm BB and Cronstein BN: Adenosine A(1) receptors regulate bone resorption in mice: Adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice. Arthritis Rheum. 62:534–541. 2010. View Article : Google Scholar : PubMed/NCBI

34 

Carroll SH, Wigner NA, Kulkarni N, Johnston-Cox H, Gerstenfeld LC and Ravid K: A2B adenosine receptor promotes mesenchymal stem cell differentiation to osteoblasts and bone formation in vivo. J Biol Chem. 287:15718–15727. 2012. View Article : Google Scholar : PubMed/NCBI

35 

Gharibi B, Abraham AA, Ham J and Evans BA: Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes. J Bone Miner Res. 26:2112–2124. 2011. View Article : Google Scholar : PubMed/NCBI

36 

Hinton DJ, McGee-Lawrence ME, Lee MR, Kwong HK, Westendorf JJ and Choi DS: Aberrant bone density in aging mice lacking the adenosine transporter ENT1. PLoS One. 9:e888182014. View Article : Google Scholar : PubMed/NCBI

37 

Tsuchiya A, Kanno T, Saito M, Miyoshi Y, Gotoh A, Nakano T and Nishizaki T: Intracellularly transported adenosine induces apoptosis in (corrected) MCF-7 human breast cancer cells by accumulating AMID in the nucleus. Cancer Lett. 321:65–72. 2012. View Article : Google Scholar : PubMed/NCBI

38 

Hiken JF and Steinberg TH: ATP downregulates P2X7 and inhibits osteoclast formation in RAW cells. Am J Physiol Cell Physiol. 287:C403–C412. 2004. View Article : Google Scholar : PubMed/NCBI

39 

Paschou SA, Dede AD, Anagnostis PG, Vryonidou A, Morganstein D and Goulis DG: Type 2 diabetes and osteoporosis: A guide to optimal management. J Clin Endocrinol Metab. 102:3621–3634. 2017. View Article : Google Scholar : PubMed/NCBI

40 

Hegazy SK: Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women. J Bone Miner Metab. 33:207–212. 2015. View Article : Google Scholar

41 

Montagnani A, Gonnelli S, Alessandri M and Nuti R: Osteoporosis and risk of fracture in patients with diabetes: An update. Aging Clin Exp Res. 23:84–90. 2011. View Article : Google Scholar : PubMed/NCBI

42 

Lee YS, Kim YS, Lee SY, Kim GH, Kim BJ, Lee SH, Lee KU, Kim GS, Kim SW and Koh JM: AMP kinase acts as a negative regulator of RANKL in the differentiation of osteoclasts. Bone. 47:926–937. 2010. View Article : Google Scholar : PubMed/NCBI

43 

Mai QG, Zhang ZM, Xu S, Lu M, Zhou RP, Zhao L, Jia CH, Wen ZH, Jin DD and Bai XC: Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. J Cell Biochem. 112:2902–2909. 2011. View Article : Google Scholar : PubMed/NCBI

44 

McCarthy AD, Cortizo AM and Sedlinsky C: Metformin revisited: Does this regulator of AMP-activated protein kinase secondarily affect bone metabolism and prevent diabetic osteopathy. World J Diabetes. 7:122–133. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ye Q, Li G, Liu S, Guan Y, Li Y, Li J, Jia H, Li X, Li Q, Huang R, Huang R, et al: Targeted disruption of adenosine kinase in myeloid monocyte cells increases osteoclastogenesis and bone resorption in mice. Int J Mol Med 41: 2177-2184, 2018.
APA
Ye, Q., Li, G., Liu, S., Guan, Y., Li, Y., Li, J. ... Zhang, Y. (2018). Targeted disruption of adenosine kinase in myeloid monocyte cells increases osteoclastogenesis and bone resorption in mice. International Journal of Molecular Medicine, 41, 2177-2184. https://doi.org/10.3892/ijmm.2018.3394
MLA
Ye, Q., Li, G., Liu, S., Guan, Y., Li, Y., Li, J., Jia, H., Li, X., Li, Q., Huang, R., Wang, H., Zhang, Y."Targeted disruption of adenosine kinase in myeloid monocyte cells increases osteoclastogenesis and bone resorption in mice". International Journal of Molecular Medicine 41.4 (2018): 2177-2184.
Chicago
Ye, Q., Li, G., Liu, S., Guan, Y., Li, Y., Li, J., Jia, H., Li, X., Li, Q., Huang, R., Wang, H., Zhang, Y."Targeted disruption of adenosine kinase in myeloid monocyte cells increases osteoclastogenesis and bone resorption in mice". International Journal of Molecular Medicine 41, no. 4 (2018): 2177-2184. https://doi.org/10.3892/ijmm.2018.3394
Copy and paste a formatted citation
x
Spandidos Publications style
Ye Q, Li G, Liu S, Guan Y, Li Y, Li J, Jia H, Li X, Li Q, Huang R, Huang R, et al: Targeted disruption of adenosine kinase in myeloid monocyte cells increases osteoclastogenesis and bone resorption in mice. Int J Mol Med 41: 2177-2184, 2018.
APA
Ye, Q., Li, G., Liu, S., Guan, Y., Li, Y., Li, J. ... Zhang, Y. (2018). Targeted disruption of adenosine kinase in myeloid monocyte cells increases osteoclastogenesis and bone resorption in mice. International Journal of Molecular Medicine, 41, 2177-2184. https://doi.org/10.3892/ijmm.2018.3394
MLA
Ye, Q., Li, G., Liu, S., Guan, Y., Li, Y., Li, J., Jia, H., Li, X., Li, Q., Huang, R., Wang, H., Zhang, Y."Targeted disruption of adenosine kinase in myeloid monocyte cells increases osteoclastogenesis and bone resorption in mice". International Journal of Molecular Medicine 41.4 (2018): 2177-2184.
Chicago
Ye, Q., Li, G., Liu, S., Guan, Y., Li, Y., Li, J., Jia, H., Li, X., Li, Q., Huang, R., Wang, H., Zhang, Y."Targeted disruption of adenosine kinase in myeloid monocyte cells increases osteoclastogenesis and bone resorption in mice". International Journal of Molecular Medicine 41, no. 4 (2018): 2177-2184. https://doi.org/10.3892/ijmm.2018.3394
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team